DLK-dependent axonal mitochondrial fission drives degeneration after axotomy

Jorge Gómez-Deza1, Matthew Nebiyou1, Mor R Alkaslasi1

  • 1Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.

Nature Communications
|December 31, 2024
PubMed

Insights

Researchers developed a human iPSC model of neurodegeneration. They found dual leucine zipper kinase (DLK) initiates an apoptotic wave via dynamin-related protein 1 (DRP1) phosphorylation, leading to neuronal death.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Neurodegenerative disorders lack effective treatments due to inadequate disease models.
  • Current models fail to accurately recapitulate human neuronal degeneration.

Purpose of the Study:

  • To develop a reproducible human induced pluripotent stem cell (iPSC)-based model for studying neurodegeneration.
  • To identify key molecular mechanisms driving neuronal cell death after injury.

Main Methods:

  • Laser axotomy was used to induce retrograde axon degeneration in human iPSC-derived neurons.
  • Time-lapse confocal imaging tracked cellular events following injury.
  • CRISPR-Cas9 technology was employed to deplete dynamin-related protein 1 (DRP1).

Main Results:

  • Laser axotomy triggered an apoptotic wave of mitochondrial fission from the injury site to the soma.
  • Dual leucine zipper kinase (DLK) was identified as the initiator of this apoptotic wave in the axon.
  • Mitochondrial fission and cell death were dependent on DLK-mediated phosphorylation of DRP1.
  • CRISPR-mediated DRP1 depletion protected mouse retinal ganglion neurons from degeneration after optic nerve crush.

Conclusions:

  • The developed human iPSC model provides a platform for studying neurodegeneration.
  • DLK-mediated DRP1 phosphorylation is a critical mechanism in damage-induced neuronal apoptosis.
  • Targeting DLK or DRP1 may offer therapeutic strategies for neurodegenerative diseases.